Curated News
By: NewsRamp Editorial Staff
February 11, 2025
ADAP Advocacy Files Amicus Curiae Briefs in Support of Patients' Rights in 340B Program
Discuss on Reddit
LinkedIn
Telegram
GithubTLDR
- ADAP Advocacy supports patients in 340B Program by challenging Health Resources Services Administration, advocating for patient-centric approach to drug pricing.
- ADAP Advocacy and CF United file amicus curiae briefs outlining flaws in 340B Program, focusing on patient care and rebate model to ensure fair pricing.
- ADAP Advocacy's efforts aim to protect patients in 340B Program, advocating for reforms to prioritize patient well-being and equitable access to healthcare.
- ADAP Advocacy highlights patient-focused approach in challenging 340B Program, emphasizing the importance of health equity and real-life impact of program reforms.
Impact - Why it Matters
This news highlights the critical need to address the shortcomings of the 340B Program and ensure that patients are not left behind in the pursuit of profits. It underscores the importance of advocating for healthcare policies that prioritize patient well-being and access to affordable care.
Summary
ADAP Advocacy and CF United filed two amicus curiae briefs supporting drug manufacturers' motion for summary judgement against the Health Resources Services Administration, highlighting how the 340B Program is failing patients. The briefs outline the program's growth, CEO compensation, and lack of corresponding charity care. ADAP Advocacy emphasizes the need to prioritize patients over providers in the 340B Program.
Source Statement
This curated news summary relied on this press release disributed by 24-7 Press Release. Read the source press release here, ADAP Advocacy Files Amicus Curiae Briefs in Support of Patients' Rights in 340B Program
